473732-48-8

Usage

Uses

Used in Pharmaceutical Research:
1-(5-methylisoxazol-3-yl)propan-1-one is used as a building block for the synthesis of various drugs and biologically active compounds. Its unique structure allows for the development of new pharmaceuticals with potential applications in treating a range of medical conditions.
Used in Agrochemical Development:
Due to its unique structure and properties, 1-(5-methylisoxazol-3-yl)propan-1-one is also used as a building block in the development of new agrochemicals, which can be utilized in the agricultural industry to improve crop protection and yield.
Used in Medicinal Chemistry:
1-(5-methylisoxazol-3-yl)propan-1-one is used as a key component in the field of medicinal chemistry for the development of new therapeutics. Its potential applications in creating novel drugs make it a valuable asset in the ongoing search for innovative treatments for various diseases and conditions.

Upstream product

• 173305-19-6 N-methoxy-N,5-dimethylisoxazole-3-carboxamide 

Downstream Products

• 1610371-61-3 2-((4S,5S)-1-(4-((2'-fluoro-5'-methoxy-3-methyl-[1,1'-biphenyl]-4-yl)methyl)phenyl)-4-methyl-3-(5-methylisoxazol-3-yl)-4,5-dihydro-1H-pyrazol-5-yl)acetic acid 

Relevant academic research and scientific papers

THIADIAZOLEDIOXIDES AND THIADIAZOLEOXIDES AS CXC- AND CC-CHEMOKINE RECEPTOR LIGANDS

Disclosed are novel compounds of the formula (IA) and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, acute pain, acute and chronic inflammatory pain, and neuropathic pain using a compound of formula (IA).

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.